Neurogene Value At Risk
| NGNE Stock | | | 19.05 -0.14 -0.73% |
The Value At Risk profile for Neurogene is based on historical price and volume observations. The dataset is based on observed market activity where data is available. Coverage may vary depending on data availability and normalization methods. Neurogene has a market cap of 295.08 M, ROE of -42.25%.
Correlation Analysis adds portfolio-level perspective. The view frames allocation within the broader portfolio. Composition figures are derived from reported holdings. The holding in Neurogene represents an allocation. This is situated within the portfolio mix. The weighting is determined by the allocation framework in use. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
For a detailed overview of how to trade Neurogene Stock, see our
How to Trade Neurogene Stock guide.
Neurogene has current Value At Risk of
-7.44. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -7.44 | |
| ER[a] | = | Expected return on investing in Neurogene |
| STD | = | Standard Deviation of Neurogene |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Neurogene is rated
below average for value at risk relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Neurogene to Peers
Other Technical Indicators